CLINICAL SYNOPSIS

Metabolic : Impaired metabolism of debrisoquine and related drugs

Neuro : Susceptibility to Parkinson disease

Oncology : Susceptibility to bladder and lung cance

Lab : Deficient hydroxylation of debrisoquin

Inheritance : Autosomal recessive (22q13.1)